Lisa Maher Selected Research

Opiate Substitution Treatment

5/2018	Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?
1/2018	Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis.
1/2017	Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
9/2014	Assessing the feasibility of hepatitis C virus vaccine trials: results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study.
9/2014	Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study.
11/2013	HIV and HCV among people who inject drugs in Central Asia.
10/2012	Correlates of susceptibility to hepatitis B among people who inject drugs in Sydney, Australia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa Maher Research Topics

Disease

51	Infections 08/2021 - 10/2006
25	Hepatitis C 11/2021 - 12/2007
12	Sexually Transmitted Diseases (Sexually Transmitted Disease) 02/2022 - 01/2009
7	HIV Infections (HIV Infection) 05/2020 - 01/2015
6	Liver Diseases (Liver Disease) 01/2020 - 11/2013
5	Hepatitis B 11/2021 - 10/2004
4	Erectile Dysfunction 01/2020 - 01/2017
4	Coinfection 01/2016 - 07/2012
3	COVID-19 01/2022 - 01/2020
3	Hepatocellular Carcinoma (Hepatoma) 07/2018 - 05/2017
2	Persistent Infection 01/2020 - 01/2017
2	Viremia 02/2019 - 01/2019
2	Fibrosis (Cirrhosis) 01/2019 - 10/2009
2	Substance-Related Disorders (Drug Abuse) 01/2019 - 01/2016
2	Drug Overdose 01/2017 - 04/2009
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2013 - 02/2012
2	Chronic Hepatitis C 05/2012 - 10/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2022
1	Virus Diseases (Viral Diseases) 11/2021
1	Seizures (Absence Seizure) 01/2019
1	Carcinoma (Carcinomatosis) 07/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Fatigue 02/2017
1	Tuberculosis (Tuberculoses) 09/2016
1	Jaundice (Icterus) 01/2016
1	Reinfection 11/2015
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 05/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2012
1	Rheumatoid Arthritis 10/2010
1	Soft Tissue Injuries (Soft Tissue Injury) 04/2009

Drug/Important Bio-Agent (IBA)

27	Pharmaceutical PreparationsIBA 01/2022 - 10/2004
15	VaccinesIBA 01/2022 - 11/2009
11	Antiviral Agents (Antivirals)IBA 08/2021 - 07/2012
10	RNA (Ribonucleic Acid)IBA 08/2021 - 10/2014
7	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021 - 01/2011
6	Heroin (Diamorphine)IBA 10/2014 - 07/2007
5	Opioid Analgesics (Opioids)IBA 11/2021 - 09/2014
3	Biological ProductsIBA 01/2021 - 12/2013
3	Methamphetamine (Desoxyn)FDA LinkGeneric 05/2020 - 01/2017
3	Methadone (Dolophine)FDA LinkGeneric 01/2020 - 12/2009
3	Broadly Neutralizing AntibodiesIBA 01/2020 - 01/2017
3	Cocaine (Cocaine HCl)IBA 01/2020 - 10/2006
2	Amyl NitriteIBA 01/2020 - 01/2017
2	EpitopesIBA 01/2020 - 01/2017
2	Illicit Drugs (Recreational Drugs)IBA 01/2019 - 05/2015
2	Interferon LambdaIBA 01/2016 - 11/2014
2	Anti-Infective Agents (Microbicides)IBA 01/2009 - 09/2008
1	Lipoprotein(a)IBA 07/2022
1	COVID-19 VaccinesIBA 01/2022
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2020
1	Immunodominant EpitopesIBA 01/2020
1	AntigensIBA 07/2019
1	Neutralizing AntibodiesIBA 01/2019
1	Phosphodiesterase 5 InhibitorsIBA 01/2017
1	InterferonsIBA 01/2017
1	UK-4IBA 01/2017
1	Glycoproteins (Glycoprotein)IBA 01/2017
1	Transaminases (Aminotransferases)IBA 01/2016
1	AntibodiesIBA 01/2016
1	Opiate AlkaloidsIBA 01/2016
1	ORALIT (ORS)IBA 05/2015
1	Nucleic AcidsIBA 05/2015
1	Biomarkers (Surrogate Marker)IBA 06/2013
1	ElementsIBA 06/2013
1	Abatacept (Orencia)FDA Link 10/2010
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2010

Therapy/Procedure

9	Therapeutics 11/2021 - 10/2010
8	Condoms (Condom) 02/2022 - 11/2011
7	Opiate Substitution Treatment 05/2018 - 10/2012
2	Art Therapy 01/2021 - 11/2013
1	Ambulatory Care (Outpatient Care) 01/2020
1	Long-Acting Reversible Contraception 01/2020
1	Patient Isolation 01/2020
1	Time-to-Treatment 10/2018
1	Off-Label Use 01/2017
1	Aftercare (After-Treatment) 11/2016
1	Treatment Delay 03/2015
1	Mechanical Ventilators (Ventilator) 01/2015
1	Highly Active Antiretroviral Therapy (HAART) 02/2012
1	Liver Transplantation 10/2009